Latest Insider Transactions at En V Veno Medical Corp (NVNO)
This section provides a real-time view of insider transactions for En V Veno Medical Corp (NVNO). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of enVVeno Medical Corp to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of enVVeno Medical Corp's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 19
2024
|
Robert Andrew Berman Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
12,000
+5.12%
|
$24,000
$2.55 P/Share
|
|
Mar 13
2024
|
Hamed Alavi Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
8,334
-100.0%
|
$50,004
$6.22 P/Share
|
|
Mar 13
2024
|
Hamed Alavi Chief Technology Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,334
+50.0%
|
$25,002
$3.59 P/Share
|
|
Sep 13
2022
|
Matthew Jenusaitis Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,041
+13.07%
|
-
|
|
Sep 13
2022
|
Robert Gray Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,041
+11.97%
|
-
|
|
Aug 16
2022
|
Francis Duhay Director |
BUY
Open market or private purchase
|
Direct |
7,751
+27.04%
|
$46,506
$6.14 P/Share
|
|
Jun 30
2022
|
Sanjay Shrivastava Director |
BUY
Open market or private purchase
|
Direct |
1,000
+20.46%
|
$3,000
$3.85 P/Share
|
|
Jun 27
2022
|
Robert Andrew Berman Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
2,500
+1.18%
|
$7,500
$3.8 P/Share
|
|
Nov 30
2021
|
Craig Glynn Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+50.0%
|
-
|
|
Nov 30
2021
|
Marc H. Glickman SVP & Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+49.6%
|
-
|
|
Nov 30
2021
|
Robert Andrew Berman Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
200,000
+49.05%
|
-
|
|
Nov 19
2021
|
Robert Andrew Berman Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
2,000
+20.54%
|
$14,000
$7.43 P/Share
|
|
Nov 16
2021
|
Robert Andrew Berman Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
2,000
+25.85%
|
$14,000
$7.87 P/Share
|
|
Nov 16
2021
|
Sanjay Shrivastava Director |
BUY
Exercise of conversion of derivative security
|
Direct |
388
+11.84%
|
-
|
|
Sep 13
2021
|
Robert Gray Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,042
+13.61%
|
-
|
|
Sep 13
2021
|
Matthew Jenusaitis Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,042
+15.04%
|
-
|
|
Aug 25
2021
|
Matthew Jenusaitis Director |
BUY
Open market or private purchase
|
Direct |
1,300
+21.17%
|
$9,100
$7.7 P/Share
|
|
Jun 16
2021
|
Robert Gray Director |
BUY
Open market or private purchase
|
Direct |
2,000
+26.41%
|
$12,000
$6.25 P/Share
|
|
May 21
2021
|
Marc H. Glickman SVP & Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
1,600
+50.0%
|
$8,000
$5.9 P/Share
|
|
May 18
2021
|
Robert Andrew Berman Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
3,000
+44.54%
|
$15,000
$5.47 P/Share
|
|
May 17
2021
|
Francis Duhay Director |
BUY
Open market or private purchase
|
Direct |
9,492
+41.9%
|
$47,460
$5.33 P/Share
|
|
Aug 21
2020
|
Biodyne Holding, S.A. |
SELL
Open market or private sale
|
Direct |
75,000
-5.07%
|
$0
$0.38 P/Share
|
|
Aug 20
2020
|
Biodyne Holding, S.A. |
SELL
Open market or private sale
|
Direct |
75,000
-4.82%
|
$0
$0.27 P/Share
|
|
Aug 19
2020
|
Biodyne Holding, S.A. |
SELL
Open market or private sale
|
Direct |
50,000
-3.11%
|
$0
$0.3 P/Share
|
|
Aug 18
2020
|
Biodyne Holding, S.A. |
SELL
Open market or private sale
|
Direct |
50,000
-3.02%
|
$0
$0.34 P/Share
|
|
Aug 14
2020
|
Biodyne Holding, S.A. |
SELL
Open market or private sale
|
Direct |
50,000
-2.93%
|
$0
$0.31 P/Share
|
|
Aug 03
2020
|
Biodyne Holding, S.A. |
SELL
Open market or private sale
|
Direct |
70,000
-3.94%
|
$0
$0.32 P/Share
|
|
Jul 31
2020
|
Biodyne Holding, S.A. |
SELL
Open market or private sale
|
Direct |
5,000
-0.28%
|
$0
$0.34 P/Share
|
|
Jul 30
2020
|
Biodyne Holding, S.A. |
SELL
Open market or private sale
|
Direct |
25,000
-1.38%
|
$0
$0.32 P/Share
|
|
Jul 21
2020
|
Biodyne Holding, S.A. |
SELL
Open market or private sale
|
Direct |
50,000
-2.69%
|
$0
$0.45 P/Share
|
|
Jul 20
2020
|
Biodyne Holding, S.A. |
SELL
Open market or private sale
|
Direct |
150,000
-7.48%
|
$0
$0.43 P/Share
|
|
Jul 18
2020
|
Matthew Jenusaitis Director |
BUY
Grant, award, or other acquisition
|
Direct |
62,500
+50.0%
|
-
|
|
Jul 17
2020
|
Biodyne Holding, S.A. |
SELL
Open market or private sale
|
Direct |
50,000
-2.43%
|
$0
$0.38 P/Share
|
|
Jul 16
2020
|
Biodyne Holding, S.A. |
SELL
Open market or private sale
|
Direct |
50,000
-2.37%
|
$0
$0.38 P/Share
|
|
Jul 06
2020
|
Biodyne Holding, S.A. |
SELL
Open market or private sale
|
Direct |
6,450
-0.31%
|
$0
$0.39 P/Share
|
|
Jul 02
2020
|
Biodyne Holding, S.A. |
SELL
Open market or private sale
|
Direct |
57,000
-2.63%
|
$0
$0.4 P/Share
|
|
Jul 01
2020
|
Biodyne Holding, S.A. |
SELL
Open market or private sale
|
Direct |
45,000
-2.03%
|
$0
$0.38 P/Share
|
|
Jun 29
2020
|
Biodyne Holding, S.A. |
SELL
Open market or private sale
|
Direct |
68,094
-2.98%
|
$0
$0.39 P/Share
|
|
Jun 26
2020
|
Biodyne Holding, S.A. |
SELL
Open market or private sale
|
Direct |
80,000
-3.39%
|
$0
$0.38 P/Share
|
|
Jun 25
2020
|
Biodyne Holding, S.A. |
SELL
Open market or private sale
|
Direct |
100,000
-4.06%
|
$0
$0.4 P/Share
|
|
Jun 24
2020
|
Biodyne Holding, S.A. |
SELL
Open market or private sale
|
Direct |
55,530
-2.21%
|
$0
$0.42 P/Share
|
|
Jun 23
2020
|
Biodyne Holding, S.A. |
SELL
Open market or private sale
|
Direct |
80,000
-3.08%
|
$0
$0.43 P/Share
|
|
Jun 22
2020
|
Biodyne Holding, S.A. |
SELL
Open market or private sale
|
Direct |
63,186
-2.37%
|
$0
$0.46 P/Share
|
|
Jun 19
2020
|
Biodyne Holding, S.A. |
SELL
Open market or private sale
|
Direct |
80,000
-2.92%
|
$0
$0.46 P/Share
|
|
Jun 18
2020
|
Biodyne Holding, S.A. |
SELL
Open market or private sale
|
Direct |
61,640
-2.2%
|
$0
$0.45 P/Share
|
|
Jun 17
2020
|
Biodyne Holding, S.A. |
SELL
Open market or private sale
|
Direct |
203,100
-6.76%
|
$0
$0.48 P/Share
|
|
Jun 16
2020
|
Biodyne Holding, S.A. |
SELL
Open market or private sale
|
Direct |
150,000
-4.75%
|
$0
$0.43 P/Share
|
|
Jun 15
2020
|
Biodyne Holding, S.A. |
SELL
Open market or private sale
|
Direct |
100,000
-3.07%
|
$0
$0.42 P/Share
|
|
Jun 11
2020
|
Biodyne Holding, S.A. |
SELL
Open market or private sale
|
Direct |
100,000
-2.98%
|
$0
$0.39 P/Share
|